Loading clinical trials...

Distributed Registry | Clinical Trials | Clareo Health

COMPLETED

Distributed Registry

Distributed Registry Study

NCT03898570•Stanford University

Summary

The purpose of this study is to test if a patient can be directly connected to a quality assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO) data will be entered into the database directly from a patient's mobile phone from their index procedure for 12 months. The investigators hope this study to be a "proof of concept" for such a distributed registry and evaluate 1) consistency of data acquisition, 2) engagement of patients, 3) overall value of patient-reported outcomes to enhance long term follow up.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Patients with cardiovascular disease who are scheduled or have undergone either a) open or endovascular vascular procedure, or b) open or percutaneous cardiac procedure.
•2. Patients with smartphones (iOS or Android) with unlimited data plans.
•3. Patients who agree to remote surveillance

Exclusion Criteria

•1. Patients unwilling to download a research study app.
•2. Data plans which are not unlimited.

Locations (2)

Palo Alto Veterans Hospital

Palo Alto, California, United States

Stanford

Palo Alto, California, United States

Key Dates

Start Date

April 1, 2019

Primary Completion Date

September 30, 2019

Completion Date

March 1, 2021

Last Updated

May 10, 2023

Enrollment

100

ACTUAL participants

Conditions

Peripheral Arterial DiseaseIntermittent ClaudicationArteriosclerosisAtherosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesSigns and SymptomsPatient Compliance

Interventions

Patient reported outcomes

BEHAVIORAL

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

NCT07472049

Peripheral Arterial DiseaseChronic Limb Threatening Ischemia

View study

RECRUITING

Advanta VXT and Flixene PMCF Registry

NCT07161583

Peripheral Arterial Disease

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 10, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Distributed Registry

Inclusion Criteria

Exclusion Criteria

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

Advanta VXT and Flixene PMCF Registry

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

VITUS Post-Market Registry

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Randomized Clinical Trial for Ewing Amputation in the VA